COVID-19 Serology Assays: To test or not to test?

Get in Touch

Our Locations

Patrice Hugo, Ph.D.

COVID-19 Serology Assays: To test or not to test?

Part 1 in this COVID-19 webinar series, presented on June 2, 2020

Overview of the immune response to COVID-19 infection
Diagnostic testing concepts
Serology tests to estimate COVID-19 exposure in the general population
How Serology tests can be the basis of “Certificate of Immunity”
Serology tests and laboratory solutions to support clinical trials

Related Thought Leaders Insights

Scientific Poster

Robust performance of single-cell multiomic analysis (CITE-Seq) demonstrated across multiple locations, replicates, and donors on challenging cryopreserved PBMC and BMMC samples

Q² Solutions is the first and only service provider to achieve the exclusive certified service partnership for CITE-Seq scRNA-Seq with BioLegend. Describes CITE-Seq performance expectations for...

Brochure

Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Factsheet

CNS Biomarkers

Rules-Based Medicine, a Q² Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...